A trial of arbidol hydrochloride in adults with COVID-19

A trial of arbidol hydrochloride in adults with COVID-19

Abstract. Background:. To date, there is no effective medicine to treat coronavirus disease 2019 (COVID-19), and the antiviral efficacy of arbidol in the treatment for COVID-19 remained equivocal and controversial. The purpose of this study was to evaluate the efficacy and safety of arbidol tablets...

Full description

Bibliographic Details
Main Authors: Jingya Zhao, Jinnong Zhang, Yang Jin, Zhouping Tang, Ke Hu, Hui Sun, Mengmeng Shi, Qingyuan Yang, Peiyu Gu, Hongrong Guo, Qi Li, Haiying Zhang, Chenghong Li, Ming Yang, Nian Xiong, Xuan Dong, Juanjuan Xu, Fan Lin, Tao Wang, Chao Yang, Bo Huang, Jingyi Zhang, Shi Chen, Qiong He, Min Zhou, Jieming Qu, Peifang Wei
Format: Article
Language:English
Published: Wolters Kluwer 2022-07-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000002104

Internet

http://journals.lww.com/10.1097/CM9.0000000000002104

Similar Items